News

NeuraLight Reaches Key Milestone with Completion of International Multicenter Parkinson’s Clinical Trial

NeuraLight Reveals the World-Class Scientific Leaders Helping to Advance Its Transformation of Disease Progression Measurement in Neurology

NeuraLight CEO Selected for 2025 Slice of Healthcare 50 Under 50 List

NeuraLight Nominated for the 2025 Prix Galien USA Award in Digital Health

NeuraLight and CHDI Foundation Collaborate to Advance Precision Eye Movement Biomarkers for Huntington's Disease

Renowned Parkinson’s Expert Prof. Olivier Rascol Appointed to Lead NeuraLight’s Scientific Advisory Board

NeuraLight Presents Results on Parkinson’s Progression at IAPRD 2025

NeuraLight launches the PARATROOPER trial to advance the understanding of Oculometric Biomarkers in Parkinsonian Disorders

NeuraLight presents at the International Parkinson and Movement Disorder Society (MDS) Congress 2024

NeuraLight recognized among World’s Best Digital Health Companies in 2024